Phase Ii trial of esorubicin in patients with advanced colorectal carcinoma
Fiore, J.; Kemeny, N.; Raymond, V.; Young, C.
Cancer Treatment Reports 70(10): 1241-1242
1986
ISSN/ISBN: 0361-5960 PMID: 3530453 Document Number: 270045
Document emailed within 1 workday
Related Documents
Locker, G.Y.; Khandekar, J.; Krauss, S.; Reisel, H.; Hoeltgen, T.; Wolter, J.; Haid, M.; Hoffman, R.; Blough, R.; Johnson, C. 1987: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial Cancer Treatment Reports 71(6): 649-650Tauer, K.; Kemeny, N.; Cheng, E.; Hollander, P.; Geller, N. 1986: Phase Ii trial of N-methylformamide in patients with advanced colorectal carcinoma Cancer Treatment Reports 70(6): 813-814
Taylor, S.G.; Desai, S.A.; DeWys, W.D. 1978: Phase Ii trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma Cancer Treatment Reports 62(8): 1203-1205
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Motzer, R.J.; Nanus, D.M.; O'Moore, P.; Scher, H.I.; Bajorin, D.F.; Reuter, V.; Tong, W.P.; Iversen, J.; Louison, C.; Albino, A.P. 1992: Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression Cancer Research 52(20): 5775-5779
Madajewicz, S.; Petrelli, N.; Rustum, Y.M.; Campbell, J.; Herrera, L.; Mittelman, A.; Perry, A.; Creaven, P.J. 1984: Phase I-Ii trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer Cancer Research 44(10): 4667-4669
Vogel, S.J.; Presant, C.A.; Ratkin, G.A.; Klahr, C. 1979: Phase i study of thymidine plus 5-fluorouracil infusions in advanced colorectal carcinoma Cancer Treatment Reports 63(1): 1-5
Magee, M.J.; Howard, J.; Bosl, G.J.; Wittes, R.E. 1985: Phase Ii trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin Cancer Treatment Reports 69(1): 125-126
Wu, R.-R.; Xiao, Z.-Y.; Wang, C.; Liu, H.-F.; Zhong, H.; Li, F. 2014: Phase Ii clinical trial of h-R3 combined with radiotherapy in locally advanced nasopharyngeal carcinoma Journal of Buon: Official Journal of the Balkan Union of Oncology 19(4): 930-936
Schulman, P.; Davis, R.B.; Rafla, S.; Green, M.; Henderson, E. 1984: Phase Ii trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study Cancer Treatment Reports 68(10): 1305-1306
Yamaguchi, Y.; Minami, K.; Kawabuchi, Y.; Emi, M. 2006: A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer Hepato-Gastroenterology 53(68): 201-205
Daniele, B.; Simmonds, P.D.; Best, L.Y.; Ross, P.J.; Cunningham, D. 1999: Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age? European Journal of Cancer 35(12): 1640-1649
Gold, E.J.; Bosl, G.J.; Itri, L.M. 1984: Phase Ii trial of 13-cis-retinoic acid in patients with advanced nonseminomatous germ cell tumors Cancer Treatment Reports 68(10): 1287-1288
Schiller, J.H.; Storer, B.; Willson, J.K.; Borden, E.C. 1987: Phase i trial of combinations of recombinant interferons beta(ser) and gamma in patients with advanced malignancy Cancer Treatment Reports 71(10): 945-952
Huang, X-dong.; Yi, J-lin.; Gao, L.; Xu, G-zhen.; Jin, J.; Yang, W-zhi.; Lu, T-xiang.; Wu, S-xiong.; Wu, R-rui.; Hu, W-han.; Xie, W-chang.; Han, F.; Gao, Y-hong.; Gao, J-ming.; Pan, J-ji.; Chen, C-ben.; Lang, J-yi.; Li, T.; Dong, Y.; Fu, Y-bing.; Fan, L.; Li, B-sen.; Li, J.; Wang, X-huai.; Chen, B-xu.; Gao, X-shu.; Zhang, P.; Wu, X-wei.; Hu, B-qiang. 2007: Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma Zhonghua Zhong Liu Za Zhi 29(3): 197-201
Kris, M.G.; Kinahan, J.J.; Gralla, R.J.; Fanucchi, M.P.; Wertheim, M.S.; O'Connell, J.P.; Marks, L.D.; Williams, L.; Farag, F.; Young, C.W. 1988: Phase i trial and clinical pharmacological evaluation of 10-ethyl-10-deazaaminopterin in adult patients with advanced cancer Cancer Research 48(19): 5573-5579
Shah, M.K.; St Marie, K.; Catalano, R.B.; Dierks, K.; Creech, R.H. 1985: Phase Ii study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma Cancer Treatment Reports 69(2): 229-230
Evans, W.K.; Shepherd, F.A.; Blackstein, M.E.; Osoba, D.; Taylor, D. 1985: Phase Ii evaluation of bisantrene in patients with advanced renal cell carcinoma Cancer Treatment Reports 69(6): 727-728
Kasuya, H.; Kodera, Y.; Nakao, A.; Yamamura, K.; Gewen, T.; Zhiwen, W.; Hotta, Y.; Yamada, S.; Fujii, T.; Fukuda, S.; Tsurumaru, N.; Kuwahara, T.; Kikumori, T.; Koide, Y.; Fujimoto, Y.; Nakashima, T.; Hirooka, Y.; Shiku, H.; Tanaka, M.; Takesako, K.; Kondo, T.; Aleksic, B.; Kawashima, H.; Goto, H.; Nishiyama, Y. 2014: Phase i Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer Hepato-Gastroenterology 61(131): 599-605
Bucior, J.; Ziółko, E.; Tomczyk, A.; Sosada, K.; Knopik, J.; Kempiński, M. 2004: Effect of palliative chemotherapy with topoisomerase inhibitor on the quality of life and survival of patients with advanced colorectal carcinoma Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(101): 457-462